[177Lu]-PSMA-617 radionuclide therapy in patients with metastatic castration-resistant prostate cancer – Author's reply. Issue 8 (August 2018) - Hofman, Michael S; Violet, John; Hicks, Rodney J; Sandhu, Shahneen